Dr. Lisa Hartling, PhD
Claim this profileStudies Gout
Studies Acute Lymphoblastic Leukemia
1 reported clinical trial
2 drugs studied
More about Lisa Hartling, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Lisa Hartling, PhD has experience with
- Blogshots 1-3
- Blogshots 4-6
Breakdown of trials Lisa Hartling, PhD has run
Acute Lymphoblastic Leukemia
Bronchiolitis
Acute Otitis Media
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lisa Hartling, PhD specialize in?
Lisa Hartling, PhD focuses on Gout and Acute Lymphoblastic Leukemia. In particular, much of their work with Gout has involved treating patients, or patients who are undergoing treatment.
Is Lisa Hartling, PhD currently recruiting for clinical trials?
No, Lisa Hartling, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Lisa Hartling, PhD has studied deeply?
Yes, Lisa Hartling, PhD has studied treatments such as Blogshots 1-3, Blogshots 4-6.
What is the best way to schedule an appointment with Lisa Hartling, PhD?
Apply for one of the trials that Lisa Hartling, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.